Global Nasal Drug Delivery Technology Market is valued at approximately USD 60.28 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2022-2028. Nasal drug delivery technology is a method of administering the drug directly into the nasal route. It offers direct contact to the systemic circulation. The growing awareness regarding the availability of nasal drug delivery and increasing patient inclination for nasal drug delivery owing to its easy administration & better efficacy is attributed to the market growth. Additionally, rising inclination towards self-administration practices, continuous product developments, growing prevalence of chronic diseases, and the increasing number of FDA approvals are the further factors that are propelling the market demand across the globe. For instance, Aptar Pharma- a leading provider of drug delivery systems declares the FDA approval in March 2019 of its Bidose nasal spray device for a breakthrough therapy in the field of depression. However, complications associated with the overuse of nasal sprays impede the growth of the market over the forecast period of 2022-2028. Also, increasing focus on alternative routes such as nasal drug delivery is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the Global Nasal Drug Delivery Technology Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rising consumer awareness regarding the availability of nasal products, and the increasing prevalence of disease associated with nasal problems. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as accessibility to the competent treatment methods, as well as the rising presence of chief companies such as Cipla Inc and AptarGroup, Inc., would create lucrative growth prospects for the Nasal Drug Delivery Technology market across the Asia-Pacific region.
Major market players included in this report are:
GlaxoSmithKline PLC
AstraZeneca PLC
Pfizer, Inc.
OptiNose, Inc.
Becton
Dickinson and Company
Promius Pharma, LLC
Cadila Pharmaceuticals Ltd.
B.F. Ascher & Company, Inc.
3M Company
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Dosage Form offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Dosage Form:
Sprays
Drops & Liquids
Powders
Gels
By Container:
Pressurized Containers
Non-pressurized Containers
By System:
Multi-dose Systems
Bi-dose Systems
Unit-dose Systems
By Therapeutic Application:
Allergic And Non-Allergic Rhinitis
Nose Congestion
Vaccination
Other Therapeutic Applications
By End-User:
Home Care Settings
Hospitals
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Nasal Drug Delivery Technology Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Nasal Drug Delivery Technology Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Nasal Drug Delivery Technology Market, by Dosage Form, 2020-2028 (USD Billion)
- 1.2.3. Nasal Drug Delivery Technology Market, by Container, 2020-2028 (USD Billion)
- 1.2.4. Nasal Drug Delivery Technology Market, by System, 2020-2028 (USD Billion)
- 1.2.5. Nasal Drug Delivery Technology Market, by Therapeutic Application, 2020-2028 (USD Billion)
- 1.2.6. Nasal Drug Delivery Technology Market, by End-User, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Nasal Drug Delivery Technology Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Nasal Drug Delivery Technology Market Dynamics
- 3.1. Nasal Drug Delivery Technology Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising awareness for the availability of nasal drug delivery
- 3.1.1.2. Growing inclination towards the self-administration practices
- 3.1.2. Market Challenges
- 3.1.2.1. Complications associated with the overuse of nasal sprays
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing focus on alternative routes such as nasal drug delivery
Chapter 4. Global Nasal Drug Delivery Technology Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Nasal Drug Delivery Technology Market, by Dosage Form
- 6.1. Market Snapshot
- 6.2. Global Nasal Drug Delivery Technology Market by Dosage Form, Performance - Potential Analysis
- 6.3. Global Nasal Drug Delivery Technology Market Estimates & Forecasts by Dosage Form, 2019-2028 (USD Billion)
- 6.4. Nasal Drug Delivery Technology Market, Sub Segment Analysis
- 6.4.1. Sprays
- 6.4.2. Drops & Liquids
- 6.4.3. Powders
- 6.4.4. Gels
Chapter 7. Global Nasal Drug Delivery Technology Market, by Container
- 7.1. Market Snapshot
- 7.2. Global Nasal Drug Delivery Technology Market by Container, Performance - Potential Analysis
- 7.3. Global Nasal Drug Delivery Technology Market Estimates & Forecasts by Container, 2019-2028 (USD Billion)
- 7.4. Nasal Drug Delivery Technology Market, Sub Segment Analysis
- 7.4.1. Pressurized Containers
- 7.4.2. Non-pressurized Containers
Chapter 8. Global Nasal Drug Delivery Technology Market, by System
- 8.1. Market Snapshot
- 8.2. Global Nasal Drug Delivery Technology Market by System, Performance - Potential Analysis
- 8.3. Global Nasal Drug Delivery Technology Market Estimates & Forecasts by System, 2019-2028 (USD Billion)
- 8.4. Nasal Drug Delivery Technology Market, Sub Segment Analysis
- 8.4.1. Multi-dose Systems
- 8.4.2. Bi-dose Systems
- 8.4.3. Unit-dose Systems
Chapter 9. Global Nasal Drug Delivery Technology Market, by Therapeutic Application
- 9.1. Market Snapshot
- 9.2. Global Nasal Drug Delivery Technology Market by Therapeutic Application, Performance - Potential Analysis
- 9.3. Global Nasal Drug Delivery Technology Market Estimates & Forecasts by Therapeutic Application, 2019-2028 (USD Billion)
- 9.4. Nasal Drug Delivery Technology Market, Sub Segment Analysis
- 9.4.1. Allergic And Non-Allergic Rhinitis
- 9.4.2. Nose Congestion
- 9.4.3. Vaccination
- 9.4.4. Other Therapeutic Applications
Chapter 10. Global Nasal Drug Delivery Technology Market, by End-User
- 10.1. Market Snapshot
- 10.2. Global Nasal Drug Delivery Technology Market by End-User, Performance - Potential Analysis
- 10.3. Global Nasal Drug Delivery Technology Market Estimates & Forecasts by End-User, 2019-2028 (USD Billion)
- 10.4. Nasal Drug Delivery Technology Market, Sub Segment Analysis
- 10.4.1. Home Care Settings
- 10.4.2. Hospitals
Chapter 11. Global Nasal Drug Delivery Technology Market, Regional Analysis
- 11.1. Nasal Drug Delivery Technology Market, Regional Market Snapshot
- 11.2. North America Nasal Drug Delivery Technology Market
- 11.2.1. U.S. Nasal Drug Delivery Technology Market
- 11.2.1.1. Dosage Form breakdown estimates & forecasts, 2019-2028
- 11.2.1.2. Container breakdown estimates & forecasts, 2019-2028
- 11.2.1.3. System breakdown estimates & forecasts, 2019-2028
- 11.2.1.4. Therapeutic Application breakdown estimates & forecasts, 2019-2028
- 11.2.1.5. End-User breakdown estimates & forecasts, 2019-2028
- 11.2.2. Canada Nasal Drug Delivery Technology Market
- 11.3. Europe Nasal Drug Delivery Technology Market Snapshot
- 11.3.1. U.K. Nasal Drug Delivery Technology Market
- 11.3.2. Germany Nasal Drug Delivery Technology Market
- 11.3.3. France Nasal Drug Delivery Technology Market
- 11.3.4. Spain Nasal Drug Delivery Technology Market
- 11.3.5. Italy Nasal Drug Delivery Technology Market
- 11.3.6. Rest of Europe Nasal Drug Delivery Technology Market
- 11.4. Asia-Pacific Nasal Drug Delivery Technology Market Snapshot
- 11.4.1. China Nasal Drug Delivery Technology Market
- 11.4.2. India Nasal Drug Delivery Technology Market
- 11.4.3. Japan Nasal Drug Delivery Technology Market
- 11.4.4. Australia Nasal Drug Delivery Technology Market
- 11.4.5. South Korea Nasal Drug Delivery Technology Market
- 11.4.6. Rest of Asia Pacific Nasal Drug Delivery Technology Market
- 11.5. Latin America Nasal Drug Delivery Technology Market Snapshot
- 11.5.1. Brazil Nasal Drug Delivery Technology Market
- 11.5.2. Mexico Nasal Drug Delivery Technology Market
- 11.6. Rest of The World Nasal Drug Delivery Technology Market
Chapter 12. Competitive Intelligence
- 12.1. Top Market Strategies
- 12.2. Company Profiles
- 12.2.1. GlaxoSmithKline PLC
- 12.2.1.1. Key Information
- 12.2.1.2. Overview
- 12.2.1.3. Financial (Subject to Data Availability)
- 12.2.1.4. Dosage Form Summary
- 12.2.1.5. Recent Developments
- 12.2.2. AstraZeneca PLC
- 12.2.3. Pfizer, Inc.
- 12.2.4. OptiNose, Inc.
- 12.2.5. Becton
- 12.2.6. Dickinson and Company
- 12.2.7. Promius Pharma, LLC
- 12.2.8. Cadila Pharmaceuticals Ltd.
- 12.2.9. B.F. Ascher & Company, Inc.
- 12.2.10. 3M Company
Chapter 13. Research Process
- 13.1. Research Process
- 13.1.1. Data Mining
- 13.1.2. Analysis
- 13.1.3. Market Estimation
- 13.1.4. Validation
- 13.1.5. Publishing
- 13.2. Research Attributes
- 13.3. Research Assumption